|Bid||14.08 x 800|
|Ask||14.09 x 800|
|Day's Range||13.58 - 14.50|
|52 Week Range||9.20 - 29.13|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 13, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.00|
Shares of Butterfly Network Inc. (BFLY) soared 5.7% on receiving its first Buy rating from Wall Street firm Cowen & Co. after it initiated coverage for the innovative digital health company. Shares closed at $14.75 on June 21. Butterfly created the world’s first handheld, single probe whole-body ultrasound system using its patented Ultrasound-on-Chip™ technology, named Butterfly iQ. The company has two revenue streams: one from sales of products such as medical devices, accessories and the other
Shares of Butterfly Network (NYSE: BFLY) have flown higher today, up by 10% as of 12:40 p.m. EDT, after getting a bullish initiation from Wall Street. Analyst Joshua Jennings assigned Butterfly Network an outperform rating alongside a price target of $20, representing approximately 43% upside from Friday's closing price. Healthcare providers pay a subscription fee to use the software platform.
Butterfly Network (NYSE: BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and contribute to the aspiration of global health equity, today announced its participation in the Cowen 6th Annual FutureHealth Conference, a virtual event taking place June 16-17, 2021.